default author photo

Nivedita Gupta

Indian Council of Medical Research (ICMR)

National Institute of Occupational Health

NIOH, Meghani Nagar

Ahemdabad, Gujarat, Gujarat 380016

India

SCHOLARLY PAPERS

3

DOWNLOADS

598

TOTAL CITATIONS

16

Scholarly Papers (3)

1.

A Phase 2/3, Observer-Blind, Randomised, Controlled Study to Assess the Safety and Immunogenicity of SII-ChAdOx1 nCOV-19 (COVID-19 Vaccine) in Adults in India

Number of pages: 32 Posted: 09 Aug 2021
Serum Institute of India Private Ltd, Indian Council of Medical Research (ICMR)Indian Council of Medical Research (ICMR) - National Institute for Research in Tuberculosis, AstraZeneca Biopharmaceuticals, KEM Hospital Research Centre - Vadu Budruk, Post Graduate Institute of Medical Education & Research (PGIMER), JSS Academy of Higher Education and Research, Mahatma Gandhi Institute of Medical Sciences, Seth G S Medical College & KEM Hospital, B J Government Medical College and Sassoon General Hospitals, Bharati Vidyapeeth (Deemed to be University) - Department of Pediatrics, Jehangir Clinical Development Centre, Topiwala National Medical College & B. Y. L. Nair Hospital, Government Medical College, Directorate of Public Health and Preventive Medicine, Indian Council of Medical Research (ICMR) - Rajendra Memorial Research Institute of Medical Sciences, Andhra Medical College, Sri Ramchandra Institute of Higher Education and Research, Serum Institute of India Private Ltd, Serum Institute of India Private Ltd, PPD India Pvt Ltd, PPD Laboratories Inc, - Vaccine Sciences Department, Indian Council of Medical Research (ICMR), Indian Council of Medical Research (ICMR), AstraZeneca Pharmaceuticals - AstraZeneca R&D, Serum Institute of India Private Ltd, Indian Council of Medical Research (ICMR), Indian Council of Medical Research (ICMR), Indian Council of Medical Research (ICMR), Serum Institute of India Private Ltd, Serum Institute of India Private Ltd, Serum Institute of India Private Ltd and Independent
Downloads 377 (195,842)
Citation 1

Abstract:

Loading...

2.

Safety and Immunogenicity Trial of an Inactivated SARS-CoV-2 Vaccine-BBV152: A Phase 1, Double-Blind, Randomised Control Trial

Number of pages: 224 Posted: 11 Dec 2020
Bharat Biotech International Ltd, Bharat Biotech International Ltd, Bharat Biotech International Ltd, Bharat Biotech International Ltd, Bharat Biotech International Ltd, Bharat Biotech International Ltd, Bharat Biotech International Ltd, National Institute of Virology-Indian Council of Medical Research (NIV-ICMR), National Institute of Virology-Indian Council of Medical Research (NIV-ICMR), National Institute of Virology-Indian Council of Medical Research (NIV-ICMR), Indian Council of Medical Research (ICMR), Indian Council of Medical Research (ICMR), Nizams Institute of Medical Sciences, - Department of Pediatrics, All India Institute of Medical Sciences (AIIMS), New Delhi, All India Institute of Medical Sciences, Patna, Redkar Hospital, Gillurkar Hospital, Prakhar Hospital, SRM Hospital and Research Centre, Institute of Medical Sciences and SUM Hospital, All India Institute of Medical Sciences (AIIMS) - Department of Pulmonary, Critical Care and Sleep Medicine and Bharat Biotech International Ltd
Downloads 160 (467,092)
Citation 10

Abstract:

Loading...

SARS-CoV-2, COVID-19, vaccine, BBV152, inactivated vaccine, th1

3.

Evaluation of Safety and Immunogenicity of an Adjuvanted, TH-1 Skewed, Whole Virion Inactivated SARS-CoV-2 Vaccine - BBV152

Number of pages: 45 Posted: 25 Nov 2020
Bharat Biotech International Ltd, Bharat Biotech International Ltd, Bharat Biotech International Ltd, Bharat Biotech International Ltd, Bharat Biotech International Ltd, Bharat Biotech International Ltd, Bharat Biotech International Ltd, RCC Labs, Government of India - Immuno-biology Lab, RCC Labs, Bharat Biotech International Ltd, Bharat Biotech International Ltd, Bharat Biotech International Ltd, National Institute of Virology-Indian Council of Medical Research (NIV-ICMR), National Institute of Virology-Indian Council of Medical Research (NIV-ICMR), National Institute of Virology-Indian Council of Medical Research (NIV-ICMR), National Institute of Virology-Indian Council of Medical Research (NIV-ICMR), National Institute of Virology-Indian Council of Medical Research (NIV-ICMR), National Institute of Virology-Indian Council of Medical Research (NIV-ICMR), National Institute of Virology-Indian Council of Medical Research (NIV-ICMR), Indian Council of Medical Research (ICMR) and Bharat Biotech International Ltd
Downloads 61 (961,006)
Citation 5

Abstract:

Loading...

SARS-CoV-2; covid vaccine; COVID-19; covaxin; BBV152